Combined estrogen plus progestin may reduce coronary heart disease risk after 5 years of use in postmenopausal women starting treatment within 10 years of menopause
- PMID: 20522676
- DOI: 10.1136/ebm1079
Combined estrogen plus progestin may reduce coronary heart disease risk after 5 years of use in postmenopausal women starting treatment within 10 years of menopause
Comment on
-
Coronary heart disease in postmenopausal recipients of estrogen plus progestin therapy: does the increased risk ever disappear? A randomized trial.Ann Intern Med. 2010 Feb 16;152(4):211-7. doi: 10.7326/0003-4819-152-4-201002160-00005. Ann Intern Med. 2010. PMID: 20157135 Free PMC article. Clinical Trial.
Publication types
LinkOut - more resources
Full Text Sources